image
Neuronetics, Inc. STIM
Healthcare - Medical - Diagnostics & Research - NASDAQ - US
Watchlist
$ 0.71
-10.1 %
$ 21.5 M
Market Cap
-0.65
P/E
CASH FLOW STATEMENT
-32 M OPERATING CASH FLOW
-4.23%
Growth Rates
1Year -4.23%
3Years -4.11%
5Years -9.24%
7Years -20.79%
10Years 0.00%
-1.32 M INVESTING CASH FLOW
-19.64%
Growth Rates
1Year -19.64%
3Years -21.89%
5Years -5.51%
7Years -22.25%
10Years 0.00%
22.7 M FINANCING CASH FLOW
10864.73%
Growth Rates
1Year 10864.73%
3Years 112.39%
5Years -25.22%
7Years 24.50%
10Years 0.00%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Neuronetics, Inc.
image
Net Income -30.2 M
Depreciation & Amortization 2.01 M
Capital Expenditures -2.37 M
Stock-Based Compensation 7.32 M
Change in Working Capital -14.1 M
Others -3.27 M
Free Cash Flow -34.4 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
OPERATING CASH FLOW
Net Income (30.2) (37.2) (31.2) (27.5) (29.0) (24.1) (16.1) (11.2)
Depreciation & Amortization 2.0 1.6 1.1 0.9 1.1 0.9 0.6 0.7
Deferred Income Tax 0 0 0 0.6 0 1.4 (0.3) 0.1
Stock Based Compensation 7.3 8.7 7.9 4.4 3.4 1.7 0.5 0.2
Other Operating Activities 2.9 0.8 0.9 1.4 1.0 1.1 0.9 0.4
Change in Working Capital (14.1) (4.8) (6.6) (8.3) (6.9) (1.6) 3.2 1.3
Cash From Operations (32.0) (30.7) (28.0) (28.4) (30.5) (20.6) (11.1) (8.5)
INVESTING CASH FLOW
Capital Expenditures (2.4) (3.3) (2.4) (0.7) (0.8) (1.0) (0.6) (0.3)
Other Items 1.0 10.0 (7.5) 0 0 0 0 0
Cash From Investing Activities (1.3) 6.7 (9.8) (0.7) (0.8) (1.0) (0.6) (0.3)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0
Total Debt Repaid 23.8 0 0 2.5 0 0 10.0 5.0
Dividends Paid 0 0 0 0 0 0 0 0
Other Financing Activities (1.1) 0.2 2.0 (0.1) 2.4 (3.0) 13.8 (0.1)
Cash From Financing Activities 22.7 0.2 83.0 2.4 2.4 97.0 23.8 4.9
CHANGE IN CASH
Net Change In Cash (10.7) (23.8) 45.2 (26.8) (28.9) 75.4 12.1 (4.0)
FREE CASH FLOW
Free Cash Flow (34.4) (34.0) (30.3) (29.1) (31.3) (21.6) (11.7) (8.9)